Association between the APOA2 promoter polymorphism and body-weight in Mediterranean and Asian populations. Replication of a gene-saturated fat interaction
暂无分享,去创建一个
E. Tai | D. Corella | J. Ordovás | R. Estruch | A. Garcia-Rios | J. Sorlí | Ó. Coltell | M. Sotos-Prieto | Suok Kai Chew
[1] D. Corella,et al. APOA2, dietary fat, and body mass index: replication of a gene-diet interaction in 3 independent populations. , 2009, Archives of internal medicine.
[2] U. Ekelund,et al. Physical activity attenuates the body mass index-increasing influence of genetic variation in the FTO gene. , 2009, The American journal of clinical nutrition.
[3] Philippe Froguel,et al. The genetic contribution to non-syndromic human obesity , 2009, Nature Reviews Genetics.
[4] C. Lynch,et al. Apolipoprotein A‐IV, a Putative Satiety/Antiatherogenic Factor, Rises After Gastric Bypass , 2009, Obesity.
[5] Ellen Kampman,et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity , 2009, Nature Genetics.
[6] Christian Gieger,et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation , 2009, Nature Genetics.
[7] J. Ioannidis,et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement , 2009, European Journal of Epidemiology.
[8] C. Bouchard. Gene–Environment Interactions in the Etiology of Obesity: Defining the Fundamentals , 2008, Obesity.
[9] E. Rampersaud,et al. Physical activity and the association of common FTO gene variants with body mass index and obesity. , 2008, Archives of internal medicine.
[10] Steven Wiltshire,et al. The apolipoprotein AII rs5082 variant is associated with reduced risk of coronary artery disease in an Australian male population. , 2008, Atherosclerosis.
[11] A. Lusis,et al. Apolipoprotein AII Is a Regulator of Very Low Density Lipoprotein Metabolism and Insulin Resistance* , 2008, Journal of Biological Chemistry.
[12] S. J. Hasstedt,et al. Type 2 Diabetes Susceptibility Genes on Chromosome 1q21–24 , 2008, Annals of human genetics.
[13] B. Balkau,et al. Evaluating the association of common APOA2 variants with type 2 diabetes , 2008, BMC Medical Genetics.
[14] T. Hansen,et al. Low Physical Activity Accentuates the Effect of the FTO rs9939609 Polymorphism on Body Fat Accumulation , 2008, Diabetes.
[15] I. Borecki,et al. The -256T>C polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study. , 2007, Clinical chemistry.
[16] Beverley Balkau,et al. Variation in FTO contributes to childhood obesity and severe adult obesity , 2007, Nature Genetics.
[17] M. Jarvelin,et al. A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.
[18] J. Suto. Quantitative trait locus analysis of plasma cholesterol levels and body weight by controlling the effects of the Apoa2 allele in mice. , 2007, The Journal of veterinary medical science.
[19] Dolores Corella,et al. Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors , 2006, Annals of Internal Medicine.
[20] Claude Bouchard,et al. The Human Obesity Gene Map: The 2005 Update , 2006, Obesity.
[21] J. Lovejoy,et al. Apolipoprotein A-II polymorphism and visceral adiposity in African-American and white women. , 2005, Obesity research.
[22] A. Lusis,et al. Mechanisms mediating insulin resistance in transgenic mice overexpressing mouse apolipoprotein A-II Published, JLR Papers in Press, October 1, 2004. DOI 10.1194/jlr.M400345-JLR200 , 2004, Journal of Lipid Research.
[23] F. Blanco-Vaca,et al. Apolipoprotein A-II, genetic variation on chromosome 1q21-q24, and disease susceptibility , 2004, Current opinion in lipidology.
[24] F. Foufelle,et al. In vitro transcriptional induction of the human apolipoprotein A-II gene by glucose. , 2004, Diabetes.
[25] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[26] K. Xiang,et al. Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. , 2004, Diabetes.
[27] M. Emi,et al. Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred , 2002, Journal of Human Genetics.
[28] P. Deurenberg,et al. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship , 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[29] Q. Ren,et al. Evaluation of apolipoprotein A-II as a positional candidate gene for familial Type II diabetes, altered lipid concentrations, and insulin resistance , 2002, Diabetologia.
[30] F. Blanco-Vaca,et al. Overexpression of human apolipoprotein A-II in transgenic mice does not increase their susceptibility to insulin resistance and obesity. , 2002, Diabetologia.
[31] F. Blanco-Vaca,et al. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. , 2001, Journal of lipid research.
[32] P. Deurenberg,et al. Relationships between indices of obesity and its co-morbidities in multi-ethnic Singapore , 2001, International Journal of Obesity.
[33] A. Hamsten,et al. Human Evidence That the Apolipoprotein A-II Gene Is Implicated in Visceral Fat Accumulation and Metabolism of Triglyceride-Rich Lipoproteins , 2001, Circulation.
[34] A. Lusis,et al. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. , 2001, Diabetes.
[35] P. Deurenberg,et al. Can dietary factors explain differences in serum cholesterol profiles among different ethnic groups (Chinese, Malays and Indians) in Singapore? , 2001, Asia Pacific journal of clinical nutrition.
[36] S. Chew,et al. Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. , 2001, Bulletin of the World Health Organization.
[37] C. Dina,et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. , 2000, American journal of human genetics.
[38] R. Elosua,et al. Validation of the Minnesota Leisure Time Physical Activity Questionnaire In Spanish Women. Investigators of the MARATDON Group. , 2000, Medicine and science in sports and exercise.
[39] M. Leppert,et al. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. , 1999, Diabetes.
[40] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[41] J. Ordóñez‐Llanos,et al. Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet. , 1998, Journal of lipid research.
[42] J. Breslow,et al. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[43] W. Willett,et al. Development and validation of a food frequency questionnaire in Spain. , 1993, International journal of epidemiology.